会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Metal-enhanced fluorescence for polarization-based affinity assays
    • 金属增强荧光用于基于偏振的亲和力测定
    • US07989220B2
    • 2011-08-02
    • US12427722
    • 2009-04-21
    • Joseph R. LakowiczHenryk Szmacinski
    • Joseph R. LakowiczHenryk Szmacinski
    • G01N33/553
    • G01N33/587G01N21/6428G01N21/6445G01N21/6452
    • A method and kit for determining the quantity of an analyte include providing a functionalized substrate and a reagent. The functionalized substrate includes metallic nanoparticles and a plurality of substantively identical bioactive target molecules affixed to a substrate. The bioactive target molecule binds to a particular analyte. The reagent includes identical detection molecules. Each detection molecule includes a fluorophore, and binds to a particular analyte or competes with a particular analyte for binding to the target molecule. The functionalized substrate is contacted to a test sample and the reagent. The functionalized substrate and a covering solution are exposed to polarized electromagnetic waves that excite the fluorophore. A quantity of the particular analyte in the test sample is determined based on measuring polarization anisotropy of fluorescent emissions from the substrate and the covering solution.
    • 用于确定分析物的量的方法和试剂盒包括提供官能化的底物和试剂。 功能化底物包括金属纳米颗粒和固定到基底上的多个基本相同的生物活性靶分子。 生物活性靶分子与特定分析物结合。 该试剂包括相同的检测分子。 每个检测分子包括荧光团,并结合特定分析物或与特定分析物竞争结合靶分子。 将功能化底物与测试样品和试剂接触。 将功能化基材和覆盖溶液暴露于激发荧光团的极化电磁波。 基于测量来自基底和覆盖溶液的荧光发射的偏振各向异性来测定测试样品中特定分析物的量。
    • 4. 发明申请
    • METAL-ENHANCED FLUORESCENCE FOR POLARIZATION-BASED AFFINITY ASSAYS
    • 金属增强荧光的基于极化的亲和力测定
    • US20090275145A1
    • 2009-11-05
    • US12427722
    • 2009-04-21
    • Joseph R. LakowiczHenryk Szmacinski
    • Joseph R. LakowiczHenryk Szmacinski
    • G01N33/566G01N21/76G01N33/553
    • G01N33/587G01N21/6428G01N21/6445G01N21/6452
    • A method and kit for determining the quantity of an analyte include providing a functionalized substrate and a reagent. The functionalized substrate includes metallic nanoparticles and a plurality of substantively identical bioactive target molecules affixed to a substrate. The bioactive target molecule binds to a particular analyte. The reagent includes identical detection molecules. Each detection molecule includes a fluorophore, and binds to a particular analyte or competes with a particular analyte for binding to the target molecule. The functionalized substrate is contacted to a test sample and the reagent. The functionalized substrate and a covering solution are exposed to polarized electromagnetic waves that excite the fluorophore. A quantity of the particular analyte in the test sample is determined based on measuring polarization anisotropy of fluorescent emissions from the substrate and the covering solution.
    • 用于确定分析物的量的方法和试剂盒包括提供官能化的底物和试剂。 功能化底物包括金属纳米颗粒和固定到基底上的多个基本相同的生物活性靶分子。 生物活性靶分子与特定分析物结合。 该试剂包括相同的检测分子。 每个检测分子包括荧光团,并结合特定分析物或与特定分析物竞争结合靶分子。 将功能化底物与测试样品和试剂接触。 将功能化基材和覆盖溶液暴露于激发荧光团的极化电磁波。 基于测量来自基底和覆盖溶液的荧光发射的偏振各向异性来测定测试样品中特定分析物的量。